These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9054048)

  • 1. [The characteristics of the hypolipidemic effect of Mevacor with its permanent multiyear use].
    Lipovetskiĭ BM
    Ter Arkh; 1996; 68(12):72-5. PubMed ID: 9054048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of familial hypercholesterolemia using Mevacor. Initial experience].
    Ceska R; Sobra J; Procházková R; Kvasilová M
    Cas Lek Cesk; 1989 May; 128(21):661-3. PubMed ID: 2758454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of severe primary hypercholesterolemia with lovastatin (Mevacor). A new therapeutic principle].
    Leth A; Munch M; Nielsen B; Dollerup J
    Ugeskr Laeger; 1990 Nov; 152(45):3354-7. PubMed ID: 2238228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A trial of long-term lovastatin treatment in patients with a heterozygous form of hereditary hypercholesterolemia].
    Alidzhanova KhG; Eliseev AO; Tvorogova MG; Buriachkovskaia LI; Chuĭkin NA; Tripol'skaia LV; Kukharchuk VV
    Ter Arkh; 1997; 69(8):13-7. PubMed ID: 9381383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A trial of the use of the hypolipidemic preparation Lipanor (ciprofibrate) in patients with primary hyperlipidemia].
    Kukharchuk VV; Rozhkova TA; Kotova LA; Tvorogova MG; Semenova OA
    Ter Arkh; 1996; 68(6):58-61. PubMed ID: 8771689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iatropathogenic effect of Mevacor on vitamin D metabolism].
    Wilczek H; Sobra J; Justová V; Ceska R; Jůzová Z; Procházková R; Kvasilová M; Pacovský V
    Cas Lek Cesk; 1989 Sep; 128(40):1254-6. PubMed ID: 2582470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of the hypolipidemic action of probucol at doses of 500 and 1000 mg/day in moderate hyperlipoproteinemia].
    Tvorogova MG; Lupanov VP; Nuraliev EIu; Zaĭtseva TM; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(8):17-21. PubMed ID: 9770737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of the multicenter controlled study of the hypolipidemic drug polycosanol in Russia].
    Nikitin IuP; Slepchenko NV; Gratsianskiĭ NA; Nechaev AS; Syrkin AL; Poltavskaia MG; Sumarokov AV; Revazov AV
    Ter Arkh; 2000; 72(12):7-10. PubMed ID: 11201841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gemfibrozil reduces elevated lipoprotein (a) levels in hypercholesterolemic patients].
    Ramires JA; Spósito AC; Mansur AP; Solimene MC; Chamone D; da Luz PL; Pileggi F
    Arq Bras Cardiol; 1997 Apr; 68(4):257-60. PubMed ID: 9497506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of pirozadil, administered continuously over four and a half years, in patients with hyperlipoproteinemia type IIa].
    Cuchi de la Cuesta C; Cuchi Alfaro MT; Cuchi Alfaro C
    Rev Clin Esp; 1989 Jan; 184(1):24-6. PubMed ID: 2704867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
    Sterna R
    Ann Acad Med Stetin; 1997; 43():67-77. PubMed ID: 9471924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
    Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Decisions regarding cholesterol-lowering therapy in the elderly: the experience in a lipid clinic and a review of the literature].
    Garrido Sanjuán JA; Pía Iglesias G; González Moraleja J; Sesma P
    An Med Interna; 1998 Jun; 15(6):305-10. PubMed ID: 9656510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
    Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication for hypercholesterolemia and the risk of nonfatal acute myocardial infarction: case-control study in Japan.
    Circ J; 2002 May; 66(5):463-8. PubMed ID: 12030341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
    Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M; Rohmer V; Farnier M; Issa-Sayegh M; Corda C; Sirugue I; Gerlinger C; Masseyeff-Elbaz MF
    Diabetes Metab; 2000 May; 26(3):184-91. PubMed ID: 10880891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic men.
    Hernández C; Lecube A; Barberá G; Chacón P; Lima J; Simó R
    Med Sci Monit; 2003 Mar; 9(3):CR114-9. PubMed ID: 12640339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.